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Summary The Walker 256 carcinosarcoma was shown to lack the enzyme 3-ketoacid CoA transferase. This
suggests that ketone bodies cannot be used as a major substrate for the energy metabolism of this tumour.
Systemic ketosis (1-2mM acetoacetate plus 3-hydroxybutyrate) was induced both in tumour-bearing and in
non-tumour-bearing rats with a diet containing 70% medium chain triglyceride. However, in rats bearing the
Walker 256 tumour, this dietary ketosis did not reduce the tumour growth rate nor did it prevent the
subsequent decrease in host body weight. Host body nitrogen losses were similarly unaffected. The ketosis
induced in tumour bearing rats was shown to be abnormal since the blood glucose concentration of ketotic,
tumour-bearing rats was significantly higher compared with that of ketotic non-tumour bearing rats
(5.2+0.4mM cf 3.4+0.6mM, P<0.01). These results may partly explain why systemic ketosis failed to alter
the growth and cachexia induced by the Walker 256 carcinosarcoma.
More than 80% of hospitalised cancer patients
show evidence of protein-energy undernutrition
(Nixon et al., 1980) and cachexia is a major contri-
buting factor to mortality in patients with
malignant disease (Warren, 1932). Often, the side
effects of ineffective antineoplastic therapy
exacerbate the nutritional consequences of
progressive tumour growth. In an attempt to break
this vicious circle, enteral and parenteral hyperali-
mentation have been extensively administered. The
results, however, have been disappointing. Host
reserves may only be partially restored (Nixon et
al., 1981) and the dominance of progressive tumour
growth has meant that survival has not been
prolonged (Brennan, 1981). This situation has
encouraged the search for alternative methods with
which to influence the host-tumour relationship.
One approach to this problem might be to
maintain host energy supply in a form which
cannot be used by the tumour. Tumour cells are
known to have a high rate of glucose consumption,
show increased rates of anaerobic glycolysis, and to
be susceptible to carbohydrate deprivation (see
Demetrakopoulos & Brennan, 1982). Alternatively,
many poorly differentiated tumours lack certain key
mitochondrial enzymes and have thus largely lost
the ability to use fat or ketone bodies for energy
production (Cederbaum & Rubin, 1976, Tisdale &
Brennan, 1983). Thus it has been proposed that
ketone bodies might be administered as a "host-
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specific" energy substrate (Tisdale & Brennan,
1983).
Furthermore, increased rates of gluconeogenesis
have been documented in humans with malignant
disease (Waterhouse et al., 1979; Holroyde et al.,
1975). This phenomenon may allow for continued
tumour growth in the wasted host, and may
account for accelerated weight loss in tumour-
bearing individuals (Gold, 1971). Dietary induced
systemic ketosis has been shown to reduce blood
glucose concentration and glucose utilisation in
man (Phinney et al., 1983). Moreover the supply of
glycerol and alanine as precursors for gluconeo-
genesis is decreased in the ketotic state (see
Robinson & Williamson, 1980). Thus, iatrogenic
ketosis has been proposed as a method of
regulating host metabolism so that host reserves are
maintained and glucose supply to the tumour is
reduced (Conyers et al., 1979; Williams &
Matthaei, 1981). Dietary induced ketosis has
already been shown to reduce by two thirds the
number of B16 melanoma deposits in the lungs of
C57B4/6 mice (Magee et al., 1979).
We have, therefore, determined the effects of
systemic ketosis on tumour growth rates, host body
composition changes and blood glucose concen-
trations in rats bearing the Walker 256 carcino-
sarcoma. This tumour has already been shown to
have few mitochondria; these are of abnormal
morphology and deficient in certain cytochromes
(see Pederson, 1978). We have also measured the
activities of the three major enzymes responsible for
the metabolism of ketone bodies as an indication of
the capacity of the tumour to utilize ketone bodies.
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Materials and methods
Animals
Inbred female Wistar rats aged between 12-14
weeks and weighing 175-205g were housed
individually. They were kept in conditions of
controlled temperature and lighting (20°C+2°C,
12/12h light/dark cycle) and allowed free access to
food (except where specified in text) and water.
Tumour
The rapidly growing Walker 256 carcinosarcoma
was obtained from the Institute of Cancer
Research, Sutton, Surrey and maintained by routine
passage every 14 days in Wistar rats. Viable tumour
fragments (100 mg) were transplanted s.c. into the
right flank under aseptic conditions and light ether
anaesthesia. Tumour doubling time was about 36h.
Diets
Standard diet The standard diet was CRM diet
(Labsure, Rank-Hovis-McDougal. Agricultural
Division, Dorset, UK). It contained 18.5% protein,
2.5% fat, 56.0% carbohydrate, 4.3% fibre, 2.4%
minerals, 15.0% moisture and added vitamins and
trace elements.
Ketogenic diet Medium chain triglyceride (MCT,
donated by Scientific Hospital Supplies Ltd.,
Liverpool UK) was mixed with the standard diet
and supplemented with protein powder (Maxipro:
Scientific Hospital Supplies) so that the two diets
contained the same quantity of protein per calorie.
Vitamin supplements were also added. The MCT
supplied 70% of the total calories and this diet is
referred to as the MCT diet.
Both diets were presented to the animals as a
paste to minimise food scatter.
Neutron activation analysis
Total body nitrogen was analysed by neutron
activation analysis (NAA) in vivo. Induced radio-
activity was measured in a modified clinical whole-
body monitor after bilateral irradiation with 14MeV
neutrons. The radiation dose equivalent was
116mSv. This non-destructive procedure allows
sequential measurements and compares well with
chemical analysis (Preston et al., 1985).
Determination oftumour enzyme activities
The activities of 3-hydroxybutyrate dehydrogenase,
acetyl CoA acetyltransferase and 3-ketoacid CoA
transferase were determined spectrophotometrically
as described previously (Tisdale & Brennan, 1983).
The tumour was surgically excised from the rat 8
days after implantation and homogenised at 4°C in
4 vol of ice cold 10-2 M Tris-HCI buffer, pH 7.4,
containing 10-3M 2-mercaptoethanol and 0.25M
sucrose. The homogenate was then further
dispersed by ultrasonic vibration for 30sec. The
homogenate was centrifuged at 300OOg for 20min
and supernatant was used for enzyme estimation.
Activity estimated in triplicate is expressed as
unitsmg-' where one unit equals the amount of
substrate converted in 1 min at 37°C.
Induction ofketosis
The Walker 256 carcinosarcoma was transplanted
into 20 rats which were fed ad libitum on the MCT
diet. Concurrently, another group of 20 tumour
free rats were fed ad libitum on the MCT diet. After
either 3, 6, 9, 12 or 15 days four animals from each
group were killed and blood was taken for the
estimation of the concentration of acetoacetate and
3-hydroxybutyrate.
Effects ofketosis on tumour weight and host body
composition
Rats were randomly assigned to four groups of 6
animals. Animals were fed on the paste diets,
contained in glass beakers, for a period of 7 days.
Food intakes were measured daily and all animals
had attained a stable food intake by the seventh
day. On the eighth day, total body nitrogen was
determined by neutron activation analysis in vivo
and this was followed by either tumour
implantation (Groups A, B, C) or sham operation
(Group D). Animals in Group A were subsequently
fed ad libitum on the standard diet and those in
group B were fed ad libitum on the MCT diet. Since
animals fed on the MCT diet ate slightly less than
those on the standard diet, Groups C and D were
included to act as controls for the reduced dietary
intake. Each animal in Group C was given a daily
ration of the standard diet equivalent in calorie
and nitrogen content, to that consumed on the
previous day by its partner animal in Group B. The
tumour-free animals (Group D) were fed on the
MCT diet and were similarly pair fed to Group B.
After 4 days all animals were killed and blood
was taken for measurement of 3-hydroxybutyrate,
acetoacetate and glucose concentrations. The
tumours were then excised and weighed. Neutron-
activation analysis of both carcasses and tumours
was then repeated.
Analysis ofrat bloodsamples
Acetoacetate and 3-hydroxybutyrate were measured
spectrophotometrically by the method ofSYSTEMIC KETOSIS AND CANCER CACHEXIA 89
Williamson & Mellanby (1974). Glucose was
measured spectrophotometrically by the method of
Bergmeyer et al. (1974).
Statistical analysis
Students t test for non-paired data was used.
Results
Enzyme activities estimated in the Walker 256
tumour
Table I shows the activities of the three major
enzymes responsible for the metabolism of ketone
bodies, estimated in an homogenate of the Walker
256 tumour. Significant activities of 3 hydroxy-
butyrate dehydrogenase and acetyl CoA acetyl-
transferase were observed. However, no activity of
the enzyme 3-ketoacid CoA transferase could be
detected in the tumour homogenate (Table I).
Table I Activity of 3-hydroxybutyrate dehydrogenase,
acetyl CoA acetyltransferase and 3-ketoacid CoA trans-
ferase in Walker 256 carcinosarcoma
Enzyme activity
Enzyme unitsmg-1 protein
3-Hydroxybutyrate dehydrogenase 4.8
Acetyl CoA acetyltransferase 12.5
3-Ketoacid CoA transferase Nil
Values represent the mean of at least three obser-
vations. Units of enzyme activity are as defined in
Materials and methods.
Effect ofthe MCT diet on blood ketone body levels
Figure 1 shows the total ketone body concentration
in blood taken from rats fed ad libitum for
various times on the MCT diet (open bars). A
significant ketosis was observed in rats fed for only
3 days on the MCT diet and this level was
maintained for at least 15 days. Also shown in
Figure 1 is the total ketone body concentration in
blood taken from rats fed ad libitum on the MCT
diet for various times after implantation of the
Walker 256 tumour (hatched bars). The level of
ketosis observed in the tumour-bearing rats was
similar to that observed in the non-tumour-bearing
rats.
Effect ofthe MCT diet on tumour growth rate and
host body weight
Host body weight before (hatched bars) and 14
days after tumour implantation into rats fed ad
libitum on the standard diet (dotted bars, Group A)
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Figure 1 Ketone body concentration estimated in
blood from rats fed for various times on the MCT
diet. Rats were either non-tumour-bearing (open bars)
or underwent tumour implantation on day 0 (hatched
bars). Values are mean +s.e. (n=4).
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Figure 2 Body weight of rats before (hatched bars)
and fourteen days after tumour implantation (dotted
bars). Final tumour weight is also shown (open bars).
Tumour bearing animals were fed either on the
standard diet ad libitum (Group A) or on the MCT
diet ad libitum (Group B). Animals in Group C were
pair fed with standard diet to those in Group B.
Animals in Group D were non-tumour bearing and
pair fed with MCT diet to those in Group B. Values
are mean +s.e. (n=6). Mean daily calorie intake of
the animals is shown within the bars. (Values are
Kcalrat-1 day -1).
is shown in Figure 2. There was a significant
decrease (by 12.0%) in the body weight of the rats
by the 14th day after tumour implantation
(P<0.01).
A similar decrease in body weight (by 14.6%)
was observed in tumour bearing rats fed ad libitum
on the MCT diet (Figure 2, Group B). The daily90 K.C.H. FEARON et al.
calorie intake of the tumour-bearing rats fed ad
libitum on the MCT diet (9.1 Kcal rat-1 day-1) was
less than that of the tumour-bearing rats fed ad
libitum on the standard diet (10.3 Kcalrat-
day-1). When tumour-bearing rats, fed on the
standard diet, were pair fed to the tumour-bearing
rats fed ad libitum on the MCT diet (Group B),
such that the mean intake of standard diet was
9.1Kcalrat-I day-1, there was a slight, but not
significant (P>0.05), increase in the host body
weight loss (Figure 2, Group C cf Group A). Non-
tumour-bearing rats restricted to a mean daily
intake of 9.1Kcalrat-1 day-1 of the MCT diet
also lost weight after 14 days of this dietary regime
(Figure 2, Group D). The weight loss of animals in
group D (12.1%) was similar to that of tumour
bearing rats fed ad libitum on the MCT diet (Group
B).
The final tumour weight was similar for all three
dietary regimes (Figure 2, open bars).
Effect ofthe MCT diet on the body composition of
tumour-bearing rats
Figure 3 shows the total nitrogen content of rats
both before (hatched bars) and 14 days after
(dotted bars) tumour implantation. The final
nitrogen content of the tumour is also shown (open
bars). The rats were fed ad libitum on either the
standard diet (Group A) or the MCT diet (Group
B). After 14 days the total nitrogen content of the
rats had decreased and the decrease was similar for
rats fed ad libitum on either the standard diet
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Figure 3 Body nitrogen content of rats before
(hatched bars) and 14 days after tumour implantation
(dotted bars). Final tumour nitrogen content is also
shown (open bars). Animal groups were as defined in
Figure 2. Values are mean + s.e. (n =6).
(0.63 gN, Group A) or the MCT diet (0.78gN,
Group B). The final nitrogen content of the tumour
was slightly greater in rats fed ad libitum on the
standard diet (0.55gN) than in rats fed ad libitum
on the MCT diet (0.46gN) but this difference was
not significant (P>0.05). When the daily intake of
the standard diet was restricted to that of the
tumour-bearing rats fed ad libitum on the MCT diet
(Group B) the final host nitrogen content and
tumour nitrogen content was similar to that of the
tumour-bearing rats fed ad libitwn on the MCT diet
(Figure 3, Group C cf Group B). When non-tumour
bearing rats were fed for 14 days on the MCT
diet but restricted to a mean daily calorie intake of
9.1 Kcal. there was a slight, but not significant
(P>0.05) decrease in the body nitrogen content
(Figure 3, Group D).
Bloodglucose andketone body concentrations of
tumour-bearing rats on the various dietary regimes
Table II shows the final blood glucose concen-
tration and total ketone body concentration of rats
fed ad libitum for 14 days on either the standard
diet (Group A) or the MCT diet (Group B). A
significant ketosis was observed in tumour-bearing
rats fed ad libitum for 14 days on the MCT diet
and this was accompanied by a significant
(P<0.02) reduction in the blood glucose concen-
tration. When the daily calorie intake of tumour-
bearing rats fed on the standard diet was restricted
to that observed in tumour-bearing rats fed ad
libitum on the MCT diet the blood ketone body
concentration was not affected but the blood
glucose concentration was reduced to a level similar
to that observed in tumour-bearing rats fed ad
libitum on the MCT diet (Table II, Group C cf
Group B). When the daily calorie intake of non-
tumour bearing rats on the MCT diet was restricted
to that of the tumour-bearing rats fed on the MCT
diet the blood ketone concentration was similar but
Table II Total ketone body concentration (acetoacetate
+3-hydroxybutyrate) and glucose concentration in blood
from rats 14 days after tumour implantation (Groups A,
B and C) and in non-tumour-bearing rats (Group D)
Total blood Bloodglucose
Group ketones (mM) (mM)
Control 0.14+0.07 6.5+0.3
A 0.25+0.09 6.2+0.3
B 2.68+0.59 5.2+0.4
C 0.29+0.08 5.3+0.2
D 2.10+0.22 3.4+0.4
Control values refer to non-tumour-bearing rats fed ad
libitum on the standard diet. Animal groups were as
defined in Figure 2. Values are mean + s.e. (n=6).SYSTEMIC KETOSIS AND CANCER CACHEXIA 91
the blood glucose concentration was significantly
reduced (Table II Group D cf Group B: P<0.01).
Discussion
These results demonstrate clearly that induction of
systemic ketosis following implantation of the
Walker 256 carcinosarcoma in rats does not reduce
the tumour growth rate, nor does it prevent the
subsequent decrease in host body weight.
Furthermore, sequential body composition analysis
of the rats indicated that the host nitrogen content
decreased to a similar extent in tumour-bearing
animals fed on the MCT diet compared with those
fed on the standard diet (Figure 3).
Two of the major enzymes responsible for the
metabolism of ketone bodies in the mitochondria,
3-hydroxybutyrate dehydrogenase and acetyl CoA
acetyltransferase, were shown to be present in
significant amounts in the Walker 256 tumour
(Table I). However, no activity of the enzyme 3-
ketoacid CoA transferase was detected. A similar
distribution of enzyme activities has been reported
for other tumours of the peripheral tissues (Tisdale
& Brennan, 1983). Since activity of the enzyme 3-
ketoacid CoA transferase determines the extent to
which 3-hydroxybutyrate is used as a metabolic fuel
(Williamson et al., 1971) it might be expected that
the Walker 256 carcinosarcoma would be unable to
metabolize ketone bodies. However, we have shown
previously that Walker 256 tumour cells grown in
vitro can form 14CO2 from D(-)3-hydroxy (3-14C-)
butyrate, but only at a very low rate due to the
presence of acetoacetyl CoA synthetase (Tisdale,
1984). Thus, although the tumour has a limited
capacity for the metabolism of acetoacetate the low
activity of acetoacetyl CoA synthetase and the
absence of 3-ketoacid CoA transferase indicates
that ketone bodies cannot be a major energy source
for this tumour.
The diet chosen for use in these studies produced
a significant systemic ketosis when fed to rats for
only 3 days; this ketosis was maintained in rats fed
on the MCT diet for at least 15 days (Figure 1).
When non-tumour-bearing rats were fed on the
MCT diet the increased concentration of ketone
bodies in the blood was accompanied by a
significant decrease (P<0.01) in the blood glucose
concentration (Table II). This is consistent with the
observation that ketosis induced in humans by a
diet containing 85% of calories as fat is associated
with a significant reduction in the blood glucose
concentration (Phinney et al., 1983). Similarly, the
induction of a systemic ketosis by the infusion of 3-
hydroxybutyrate into man (Sherwin et al., 1975),
dogs (Binkiewicz et al., 1974) or sheep (Radcliffe et
al., 1983) has been shown to produce a significant
decrease in the blood glucose concentration and is
associated with a decrease in the rate of gluconeo-
genesis of both fed and fasted sheep (Radcliffe et
al., 1983). However, although a similar degree of
ketosis was induced in both tumour bearing and
non-tumour-bearing rats fed on the MCT diet
(Figure 2) the decrease in the blood glucose concen-
tration of tumour-bearing rats, though significant,
was much less marked (Table II). Furthermore, the
limited decrease in blood glucose concentration of
tumour-bearing rats fed ad libitum on the MCT diet
could be accounted for by the decrease in their
daily calorie intake since tumour-bearing rats fed
an equicaloric amount of the standard diet had a
similar blood glucose concentration (Table II).
In septic sheep systemic ketosis is not
accompanied either by a decrease in the blood
glucose concentration or by a decrease in the rate
of glucose production by the liver (Radcliffe et al.,
1983). This observation lends support to the
suggestion that the metabolic abnormalities
observed in the tumour-bearing host resemble some
of those characteristic of semi-starvation but also
some of those characteristic of sepsis and trauma
(Brennan, 1977). The mechanism accounting for the
failure of systemic ketosis to lower blood glucose in
sepsis or cancer cachexia remains obscure. It may,
however, be related to the insulin resistance
characteristic ofboth metabolic states.
The failure of the ketogenic diet to restrict
tumour growth may be, therefore, a result of the
failure of ketosis to reduce the availability of
glucose in tumour-bearing rats. It has already been
shown that the growth rate of the Walker 256
tumour in rats can be decreased following admini-
stration of the glucose antimetabolite 2-deoxy-
glucose (Ball et al., 1957) or following admini-
stration of hydrazine sulphate which inhibits gluco-
neogenesis (Gold, 1971). This suggests that the
Walker 256 tumour is largely dependent upon
glucose as an energy substrate. Thus, although the
tumour cells are probably unable to use ketone
bodies as a major energy source, the ketogenic diet
did not restrict the supply of glucose to the tumour
cells and thus failed to deprive the tumour of an
important energy source.
The final tumour weight in rats fed ad libitum on
the MCT diet was slightly, but not significantly
(P>0.05) less than that in rats fed ad libitum on the
standard diet (Figure 2, Group B cf Group A). The
slight decrease in tumour growth rate can be
accounted for entirely by the reduced calorie intake
since a similar decrease in the final tumour'size was
observed in rats that had a daily allowance of the
standard diet equal in calorie content to that eaten
by rats fed on the MCT diet (Figure 2, Group C cf
Group B).92 K.C.H. FEARON et al.
There was a significant (P<0.01) decrease in the
total nitrogen content of all tumour-bearing rats
regardless of the dietary regimen (Figure 3). In all
cases at least 60% of the host nitrogen loss could
be accounted for by the nitrogen content of the
tumour. This observation clearly supports the
conclusion that the cachexia associated with the
growth of the Walker 256 carcinosarcoma in rats is
due mostly to the tumour acting as a "nitrogen
trap" for the host's amino acids (Mider et al.,
1948).
Although we cannot conclude from this study
that a host specific substrate does not restrict
tumour growth, the results indicate the difficulty of
such an approach to cancer treatment. The presence
of metabolic abnormalities in cancer-bearing
patients has been widely documented (see Fearon
et al., 1985) and these abnormalities alter the host's
response to dietary modification. It is possible,
however, that administration of a glucose antimeta-
bolite or an inhibitor of gluconeogenesis as well as
the ketogenic diet may be a means of providing a
host specific substrate.
This work has been supported by a grant from the Cancer
Research Campaign.
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